Un-Audited Financial Results (Standalone & Consolidated) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2026

Filed: 12 Aug 2026, 20:17 IST Exchange: BSE Category: Financial Results — Unaudited Quarterly Results

Q1FY27 results (unaudited): Standalone: Revenue 4.4bn +41% y-y (3.1bn) PAT (Loss) -0.10bn (loss 0.06bn) Consolidated: Revenue 23.6bn +26% y-y (18.8bn) PAT (Loss) -0.47bn (profit 0.08bn) Dividend: Company continues to be barred from declaring dividends as per RBI letter issued in December 2019. Commentary: Q1 FY27 demonstrates disciplined operational execution across portfolio with 37% GWP growth in Care Health Insurance and strategic capital deployment across financial services businesses.

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 RELIGARE — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add RELIGARE to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Religare Enterprises Limited

Important. The summary above is generated automatically from Religare Enterprises Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.